2.4.0.8129 - Disclosure - Endo License and Development Agreement - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE71016---1310-Q0006_STD_92_20130630_0http://www.sec.gov/CIK0001103021duration2013-03-31T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE71016---1310-Q0006_STD_91_20120630_0http://www.sec.gov/CIK0001103021duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE71016---1310-Q0006_STD_181_20130630_0http://www.sec.gov/CIK0001103021duration2013-01-01T00:00:002013-06-30T00:00:00MilestoneStandardhttp://www.bdsi.com/20130630Milestonebdsi0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE71016---1310-Q0006_STD_182_20120630_0http://www.sec.gov/CIK0001103021duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE71016---1310-Q0006_STD_366_20121231_0http://www.sec.gov/CIK0001103021duration2012-01-01T00:00:002012-12-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDfalsefalse$eol_PE71016---1310-Q0006_STD_0_20120117_0http://www.sec.gov/CIK0001103021instant2012-01-17T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$eol_PE71016---1310-Q0006_STD_31_20120531_0_928294x970604http://www.sec.gov/CIK0001103021duration2012-05-01T00:00:002012-05-31T00:00:00falsefalseEndo License and Development Agreement [Member]us-gaap_TypeOfArrangementAxisxbrldihttp://xbrl.org/2006/xbrldibdsi_EndoLicenseAndDevelopmentAgreementMemberus-gaap_TypeOfArrangementAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_RevenueRecognitionMilestoneMethodLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue Recognition, Milestone Method [Line Items]2false 4bdsi_NonRefundablePaymentReceivedbdsi_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse3000000030000000USD$falsetruefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNon refundable payment received.No definition available.false2Non-refundable payment received3false 4bdsi_PotentialMilestonePaymentReceivablebdsi_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse9500000095000000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse9500000095000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPotential milestone payment receivable.No definition available.false2Potential milestone payments4false 4bdsi_NumberOfPotentialMilestonePaymentsbdsi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse66falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of potential milestone payments.No definition available.false256Number of potential milestone payments5false 4bdsi_PotentialMilestonePaymentReceivableIntellectualPropertybdsi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse3500000035000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPotential milestone payment receivable intellectual property.No definition available.false2Potential milestone payments on intellectual property rights6false 4bdsi_PotentialMilestonePaymentOnIssuanceOfPatentbdsi_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1500000015000000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1500000015000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPotential milestone payment on issuance of patent.No definition available.false2Potential milestone payments on issuance of patent7false 4bdsi_PotentialMilestonePaymentReceivableClinicalDevelopmentbdsi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse2000000020000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPotential milestone payment receivable clinical developmentNo definition available.false2Potential milestone payment receivable clinical development8false 4bdsi_PotentialMilestonePaymentReceivableRegulatoryEventsbdsi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse4000000040000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPotential milestone payment receivable regulatory events.No definition available.false2Potential milestone payment receivable regulatory events9false 4bdsi_PaymentsReceivableOnAchievementOfPotentialSalesMilestonesbdsi_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5500000055000000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse5500000055000000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPayments receivable on achievement of potential sales milestones.No definition available.false2Payment receivable on achievement of potential sales milestones10false 4bdsi_NumberOfPotentialSalesMilestonesbdsi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse44falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of potential sales milestones.No definition available.false256Number of potential sales milestones11false 4bdsi_RecognizedUpFrontPaymentAllocatedToLicensebdsi_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1560000015600000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRecognized up-front payment allocated to license.No definition available.false2Recognized up-front payment allocated to the license12false 4bdsi_RecognizedUpFrontPaymentToClinicalTrialMaterialAndDevelopmentServicesbdsi_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1440000014400000falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRecognized up-front payment to clinical trial material and development services.No definition available.false2Recognized up-front payment to clinical trial material and development services13false 4bdsi_UpfrontFeesAssignedToDeliverablesConsistingOfIntellectualPropertyComponentValuebdsi_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryUpfront fees assigned to deliverables consisting of intellectual property component value.No definition available.false2Upfront payment14false 4us-gaap_ContractsRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19089491908949falsefalsefalse2truefalsefalse1629797216297972falsefalsefalse3truefalsefalse35309263530926falsefalsefalse4truefalsefalse3280213732802137falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse1500000015000000falsefalsefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Aggregate milestones and services revenue recognized15false 4bdsi_EstimatedAmountRecognizedAgainstClinicalServicesDeliverablebdsi_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse34000003400000falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse52000005200000falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryEstimated amount recognized against clinical services deliverable.No definition available.false2Estimated amount recognized against clinical services deliverable16false 4bdsi_DeferredRevenueResearchAndDevelopmentbdsi_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse59000005900000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse59000005900000USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryDeferred revenue research and development.No definition available.false2Deferred revenue income of the research and development activities17false 4bdsi_LicenseAndDevelopmentAgreementTermbdsi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse0010 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaLicense and development agreement term.No definition available.false0Term of Endo Agreement18false 4bdsi_ExtendedPatentOnDrugDeliveryTechnologybdsi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse002020 to 2027falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringExtended patent on drug delivery technology.No definition available.false0Extended patent on drug delivery technologyfalseEndo License and Development Agreement - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.bdsi.com/taxonomy/role/DisclosureEndoLicenseAndDevelopmentAgreementAdditionalInformation718